Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children
A Prospective Observational Study in a Tertiary Pediatric Hospital in Beijing to Understand the Accuracy of Bronchodilator Response (BDR) in Chinese Controller Naive Asthmatic Children Between the Age of 4~12 Years Old
Sponsor: Capital Institute of Pediatrics, China
This observational or N/A phase trial investigates Asthma and is currently completed. Capital Institute of Pediatrics, China leads this study, which shows 10 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jun 2022 — Dec 2022 [monthly]
Completed
▶ Show 5 earlier versions
-
Oct 2021 — Jun 2022 [monthly]
Completed
Status: Unknown Status → Completed
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Capital Institute of Pediatrics, China
- Merck Sharp & Dohme LLC
For direct contact, visit the study record on ClinicalTrials.gov .